Tylenol, a no-no after gastric bypass? Maybe. Down the road, if confirmed in future large study –
This is slightly terrifying to me, a nearly nine-year roux-en-y patient who left the bariatric surgery hospital taking acetaminophen melted in a one-ounce dose cup of warm water. I have depended on Tylenol caplets, capsules and liquids for nine years along with my re-routed-intestines husband who also depends on the stuff for aches and pains.
Those who DRINK alcohol BE WARNED.
Paracetamol INN ( /ˌpærəˈsiːtəmɒl/ or /ˌpærəˈsɛtəmɒl/), or acetaminophen USAN i/əˌsiːtəˈmɪnəfɨn/, chemically named N-acetyl-p-aminophenol, is a widely used over-the-counter analgesic(pain reliever) and antipyretic (fever reducer). It is commonly used for the relief of headaches and other minor aches and pains and is a major ingredient in numerous cold and flu remedies. In combination with opioid analgesics, paracetamol can also be used in the management of more severe pain such as post-surgical pain and providing palliative care in advanced cancer patients. The onset of analgesia is approximately 11 minutes after oral administration of paracetamol, and its half-life is 1–4 hours. Though acetaminophen is used to treat inflammatory pain, it is not generally classified as an NSAID because it exhibits only weak anti-inflammatory activity.
While generally safe for use at recommended doses (1,000 mg per single dose and up to 4,000 mg per day for adults), acute overdoses of paracetamol can cause potentially fatal liver damage and, in rare individuals, a normal dose can do the same; the risk may be heightened by chronic alcohol abuse, though it is lessened by contemporary alcohol consumption.Paracetamol toxicity is the foremost cause of acute liver failure in the Western world, and accounts for most drug overdoses in the United States, the United Kingdom, Australia and New Zealand
We depend on acetaminophen because We Have Been Trained Not To Touch NSAIDS! What then if acetaminophen is off the table for use? What do we use for over the counter pain medication? It's hard enough that pain medications after gastric bypass DO NOT WORK THE SAME and it is hard to find something that TAKES THE EDGE OFF OF any pain. Even just something as simple as menses and cyst pain is not touched by NSAIDS (not that I would know, I promise… a little) or acetaminophen.
What do we do when there are no options?
Researchers at California Pacific Medical Center (CPMC) reported an alarming rate of bariatric surgery among patients with ALF from acetaminophen poisoning. They studied 101 patients with ALF between 2009 and 2011, of whom 54 had acetaminophen-induced ALF. Of those 54 patients 9 – or 16.7 percent – had prior bariatric surgery, as compared to none of the 47 patients with ALF from other causes. The prevalence of bariatric surgery in the American population is approximately 0.66 percent.
When asked about the large percentage of patients with acetaminophen-induced ALF who had bariatric surgery, Dr. Edward Holt said, "While it is possible that this percentage could be lower in a study with a larger sample size, it is not likely that a difference this large would disappear. To the best of our knowledge, this is the first report of bariatric surgery in acetaminophen-induced ALF."
In the United States more than one million adults between the ages of 18 and 75 years have had bariatric surgery. "If these patients are predisposed to liver injury from acetaminophen, then clinical management and drug advertising should immediately be updated to reflect this risk," said Dr. Holt.
When asked about future directions of research in this area, Dr. Holt said "We would like see these findings reproduced in a larger, multi-center study, and we want to look at the pharmacokinetics of acetaminophen in patients with and without bariatric surgery."
The CPMC researchers called attention to previously reported associations between bariatric surgery and suicide, and between alcohol abuse and acetaminophen-induced ALF. They showed that patients in their study with prior bariatric surgery and acetaminophen-induced ALF did not have higher rates of depression, alcohol abuse, or intent to cause self-harm when compared to patients with other causes of ALF.
The authors concluded that prior bariatric surgery may place patients at higher risk for acetaminophen poisoning, similar to the increased risk seen in patients who chronically abuse alcohol. "Patients with chronic alcohol abuse who take 4 grams of acetaminophen each day can inadvertently poison themselves and even develop acetaminophen-induced ALF. Based on our results, we suspect that bariatric surgery may also render patients more susceptible to acetaminophen-induced liver injury. However, before an official warning is issued further research should be conducted." concluded Dr. Holt.
|CONTROL ID: 1423621|
|PRESENTATION TYPE: Oral or Poster|
|CURRENT CATEGORY: Acute Liver Failure and Artificial Liver Support|
|CURRENT DESCRIPTORS: A01. Acute Liver Failure and Artificial Liver Support|
|TITLE: Prior Bariatric Surgery Increases the Risk of Acute Liver Failure from Acetaminophen Poisoning|
|AUTHORS (FIRST NAME, LAST NAME): Edward W. Holt1, Timothy J. Davern1|
|INSTITUTIONS (ALL): 1. Department of Transplantation, Division of Hepatology, California Pacific Medical Center, San Francisco, CA, United States.|
ABSTRACT BODY: Background: Bariatric surgery (BS) is an effective therapy for morbid obesity, a major public health problem in the U.S. Previous reports suggest that following BS, higher peak serum concentrations of ethanol (ETOH) after a challenge, and a higher rate of suicide compared to matched controls are observed. We hypothesized that prior BS might also predispose patients to an increased risk of acetaminophen (APAP)-related liver injury.
Purpose: To report the prevalence of BS in a cohort of patients with APAP-induced acute liver failure (APAP-ALF) and to compare this to both the prevalence among patients with non APAP-ALF and to the estimated national prevalence of BS. Differences between groups were compared using Fischer’s exact test, chi-square test and Student’s t-test.
Methods: Patients with ALF were prospectively identified between 2009 and 2011 using standard criteria (Larson et al. Hepatology 2005). The population prevalence of BS was estimated from the published literature, including the National Hospital Discharge Survey.
Results: 101 patients with ALF were identified; 54 with APAP-ALF and 47 with non APAP-ALF. 9 of 54 (16.7%) with APAP-ALF had prior BS (8 roux-en-Y gastric bypass; 1 duodenal switch, mean 5.9 (±2.8) years before presentation) compared to 0 of 47 with non APAP-ALF (p=0.003). The prevalence of BS in the APAP-ALF cohort was roughly 30-fold higher than the estimated prevalence (0.5%) in the general U.S. population (p = 0.0001). In the APAP-ALF cohort there were no differences in age, gender or need for liver transplantation between patients with and without prior BS (p>0.05 for all), but the group with prior BS had a lower prevalence of depression and ETOH abuse (p=0.04 and p=0.03, respectively). Importantly, BS patients did not have a higher rate of intent to self-harm (22.2% with prior BS vs. 35.6% without prior BS, p=0.4). In the APAP-ALF cohort, no patients with prior BS died compared to 8 patients (17.8%) without prior BS (p=0.16).
Conclusions: In a cohort of patients with ALF the prevalence of prior bariatric surgery was dramatically higher in patients with APAP-ALF compared to non APAP-ALF patients and to the general U.S. population. Importantly, patients with APAP-ALF and BS in our cohort did not have a higher incidence of depression, ETOH abuse or intentional overdose than in APAP-ALF patients without BS. These data suggest that bariatric surgery is a risk factor for severe liver injury from APAP.
This novel finding, if confirmed in a larger multi-center cohort, should lead to specific warnings for APAP use in bariatric patients similar to those already in place for patients who drink excessive alcohol.